2,016
Views
1
CrossRef citations to date
0
Altmetric
Reviews

Potentially modifiable associates of anxiety in people with multiple sclerosis: a systematic review

ORCID Icon & ORCID Icon
Pages 8201-8212 | Received 27 Jan 2021, Accepted 20 Dec 2021, Published online: 18 Jan 2022

References

  • Thompson AJ, Baranzini ES, Geurts J, et al. Multiple sclerosis. Lancet. 2018;391(10130):1622–1636.
  • Rahn K, Slusher B, Kaplin A. Cognitive impairment in multiple sclerosis: a forgotten disability remembered. In: Cerebrum: the Dana forum on brain science. Vol. 2012. Dana Foundation; 2012.
  • Dua T, Rompani P, Multiple Sclerosis International Federation, et al. Atlas: multiple sclerosis resources in the world. Geneva, Switzerland: World Health Organization; 2008.
  • Thornton EW, Tedman S, Rigby S, et al. Worries and concerns of patients with multiple sclerosis: development of an assessment scale. Mult Scler. 2006;12(2):196–203.
  • Boeschoten RE, Braamse AMJ, Beekman ATF, et al. Prevalence of depression and anxiety in multiple sclerosis: a systematic review and meta-analysis. J Neurol Sci. 2017;372:331–341.
  • Alsaadi T, El Hammasi K, Shahrour TM, et al. Depression and anxiety as determinants of health-related quality of life in patients with multiple sclerosis – United Arab Emirates. Neurol Int. 2017;9(4):7343–7378.
  • Hviid LE, Healy BC, Rintell DJ, et al. Patient reported outcomes in benign multiple sclerosis. Mult Scler. 2011;17(7):876–884.
  • Fiest KM, Walker JR, Bernstein CN, et al. Systematic review and meta-analysis of interventions for depression and anxiety in persons with multiple sclerosis. Mult Scler Relat Disord. 2016;5:12–26.
  • Mohr DC, Cox D, Merluzzi N. Self-injection anxiety training: a treatment for patients unable to self-inject injectable medications. Mult Scler. 2005;11(2):182–185.
  • Zorzon M, de Masi R, Nasuelli D, et al. Depression and anxiety in multiple sclerosis. A clinical and MRI study in 95 subjects. J Neurol. 2001;248(5):416–421.
  • Morrow SA. Anxiety is more important than depression in MS – yes. Mult Scler. 2018;24(4):440–441.
  • Bruce JM, Arnett P. Clinical correlates of generalized worry in multiple sclerosis. J Clin Exp Neuropsychol. 2009;31(6):698–705.
  • Butler E, Matcham F, Chalder T. A systematic review of anxiety amongst people with multiple sclerosis. Mult Scler Relat Disord. 2016;10:145–168.
  • Orr J, Bernstein CN, Graff LA, et al. Factors associated with perceived need for mental health care in multiple sclerosis. Mult Scler Relat Disord. 2018;25:179–185.
  • Marrie RA, Reingold S, Cohen J, et al. The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review. Mult Scler. 2015;21(3):305–317.
  • Bigaut K, Cohen M, Durand-Dubief F, et al. How to switch disease-modifying treatments in multiple sclerosis: guidelines from the French Multiple Sclerosis Society (SFSEP). Mult Scler Relat Disord. 2021;53:103076.
  • Mohr DC, Cox D, Epstein L, et al. Teaching patients to self-inject: pilot study of a treatment for injection anxiety and phobia in multiple sclerosis patients prescribed injectable medications. J Behav Ther Exp Psychiatry. 2002;33(1):39–47.
  • Ouzzani M, Hammady H, Fedorowicz Z, et al. Rayyan—a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210.
  • Lisy K, Porritt K. Narrative synthesis: considerations and challenges. JBI Evid Implement. 2016;14(4):201.
  • Hong QN, Fàbregues S, Bartlett G, et al. The Mixed Methods Appraisal Tool (MMAT) version 2018 for information professionals and researchers. Educ Inform. 2018;34(4):285–291.
  • Quinn E, Hynes SM. Occupational therapy interventions for multiple sclerosis: a scoping review. Scand J Occup Ther. 2021;28(5):399–414.
  • Ow N, Mozafarinia M, Mayo NE. Quality of life measures in pediatric multiple sclerosis: a systematic review and meta‐analysis. Dev Med Child Neurol. 2021;63(9):1051–1058.
  • Power M, Arafa N, Wenz A, et al. Perceptions of fatigue and fatigue management interventions among people with multiple sclerosis: a systematic literature review and narrative synthesis. Int J Ther Rehabil. 2021;28(6):1–21.
  • Pace R, Pluye P, Bartlett G, et al. Testing the reliability and efficiency of the pilot Mixed Methods Appraisal Tool (MMAT) for systematic mixed studies review. Int J Nurs Stud. 2012;49(1):47–53.
  • Anagnostouli M, Babili I, Chrousos G, et al. A novel cognitive-behavioral stress management method for multiple sclerosis. A brief report of an observational study. Neurol Res. 2019;41(3):223–226.
  • Henry A, Tourbah A, Camus G, et al. Anxiety and depression in patients with multiple sclerosis: the mediating effects of perceived social support. Mult Scler Relat Disord. 2019;27:46–51.
  • Uccelli MM, Traversa S, Ponzio M. A survey study comparing young adults with MS and healthy controls on self-esteem, self-efficacy, mood and quality of life. J Neurol Sci. 2016;368:369–373.
  • McKay KA, Tremlett H, Fisk JD, et al. Adverse health behaviours are associated with depression and anxiety in multiple sclerosis: a prospective multisite study. Mult Scler. 2016;22(5):685–693.
  • Comber L, Coote S, Finlayson M, et al. An exploration of fall-related, psychosocial variables in people with multiple sclerosis who have fallen. Br J Occup Ther. 2017;80(10):587–595.
  • Grech LB, Kiropoulos LA, Kirby KM, et al. Coping mediates and moderates the relationship between executive functions and psychological adjustment in multiple sclerosis. Neuropsychology. 2016;30(3):361–376.
  • Bogart KR. Disability identity predicts lower anxiety and depression in multiple sclerosis. Rehabil Psychol. 2015;60(1):105–109.
  • Van Damme S, De Waegeneer A, Debruyne J. Do flexible goal adjustment and acceptance help preserve quality of life in patients with multiple sclerosis? Int J Behav Med. 2016;23(3):333–339.
  • Casey B, Uszynski M, Hayes S, et al. Do multiple sclerosis symptoms moderate the relationship between self-efficacy and physical activity in people with multiple sclerosis? Rehabil Psychol. 2018;63(1):104–110.
  • Hasanpour-Dehkordi A, Jivad N, Solati K. Effects of yoga on physiological indices, anxiety and social functioning in multiple sclerosis patients: a randomized trial. J Clin Diagn Res. 2016;10(6):VC01–VC05.
  • Jongen P, van Mastrigt G, Heerings M, et al. Effect of an intensive 3-day social cognitive treatment (can do treatment) on control self-efficacy in patients with relapsing remitting multiple sclerosis and low disability: a single-centre randomized controlled trial. PLOS One. 2019;14(10):e0223482.
  • Coote S, Uszynski M, Herring MP, et al. Effect of exercising at minimum recommendations of the multiple sclerosis exercise guideline combined with structured education or attention control education – secondary results of the step it up randomised controlled trial. BMC Neurol. 2017;17(1):119–114.
  • Prakash RS, Schirda B, Valentine TR, et al. Emotion dysregulation in multiple sclerosis: impact on symptoms of depression and anxiety. Mult Scler Relat Disord. 2019;36:101399.
  • Kalron A, Aloni R, Givon U, et al. Fear of falling, not falls, impacts leisure-time physical activity in people with multiple sclerosis. Gait Posture. 2018;65:33–38.
  • Sparling A, Stutts LA, Sanner H, et al. In-person and online social participation and emotional health in individuals with multiple sclerosis. Qual Life Res. 2017;26(11):3089–3097.
  • Jongen PJ, Heerings M, Ruimschotel R, et al. An intensive social cognitive program (can do treatment) in people with relapsing remitting multiple sclerosis and low disability: a randomized controlled trial protocol. BMC Neurol. 2016;16(1):81.
  • Gascoyne CR, Simpson S, Chen J, et al. Modifiable factors associated with depression and anxiety in multiple sclerosis. Acta Neurol Scand. 2019;140(3):204–211.
  • Yael G, Nancy C, John D. Money management in multiple sclerosis: the role of cognitive, motor, and affective factors. Front Neurol. 2019;10:1128.
  • Giordano A, Liethmann K, Köpke S, et al. Risk knowledge of people with relapsing-remitting multiple sclerosis: results of an international survey. PLOS One. 2018;13(11):e0208004.
  • Keikhaei A, Sargazi GH, Saeedinezhad F, et al. The effect of motor-balance exercise on MS patients' anxiety and fatigue of Zahedan, Iran, 2014–2015. Med Sci. 2018;22(89):92–98.
  • Valvano A, Floyd RM, Penwell-Waines L, et al. The relationship between cognitive fusion, stigma, and well-being in people with multiple sclerosis. J Context Behav Sci. 2016;5(4):266–270.
  • Mioduszewski O, MacLean H, Poulin PA, et al. Trait mindfulness and wellness in multiple sclerosis. Can J Neurol Sci. 2018;45(5):580–582.
  • Pagnini F, Cavalera C, Rovaris M, et al. Longitudinal associations between mindfulness and well-being in people with multiple sclerosis. Int J Clin Health Psychol. 2019;19(1):22–30.
  • Pham T, Jetté N, Bulloch AGM, et al. The prevalence of anxiety and associated factors in persons with multiple sclerosis. Mult Scler Relat Disord. 2018;19:35–39.
  • Shaygannejad V, Mirmosayyeb O, Nehzat N, et al. Fear of relapse, social support, and psychological well-being (depression, anxiety, and stress level) of patients with multiple sclerosis (MS) during the COVID-19 pandemic stage. Neurol Sci. 2021;42(7):2615–2614.
  • Contentti EC, López PA, Criniti J, et al. Use of cannabis in patients with multiple sclerosis from Argentina. Mult Scler Relat Disord. 2021;51:102932.
  • Ramezani N, Ashtari F, Bastami EA, et al. Fear and anxiety in patients with multiple sclerosis during COVID-19 pandemic; report of an Iranian population. Mult Scler Relat Disord. 2021;50:102798.
  • Altınkaynak Yılmaz T, Ozdelikara A. The effect on the anxiety level of the social support given to multiple sclerosis patients. Perspect Psychiatr Care; 2021.
  • Sbragia E, Colombo E, Pollio C, et al. Embracing resilience in multiple sclerosis: a new perspective from COVID-19 pandemic. Psychol Health Med. 2021;1–9.
  • Fleming KM, Coote SB, Herring MP. Home-based Pilates for symptoms of anxiety, depression and fatigue among persons with multiple sclerosis: an 8-week randomized controlled trial. Mult Scler. 2021;27(14):2267–2279.
  • Alschuler KN, Roberts MK, Herring TE, et al. Distress and risk perception in people living with multiple sclerosis during the early phase of the COVID-19 pandemic. Mult Scler Relat Disord. 2021;47:102618.
  • Seddighi-Khavidak M, Tahan N, Akbarzadeh-Baghban A. Comparing the effects of vestibular rehabilitation with and without lavender oil scents as an olfactory stimulus on balance, fear of falling down and activities of daily living of people with multiple sclerosis: a randomized clinical trial. Disabil Rehabil. 2020;1–7.
  • Ratajska A, Glanz BI, Chitnis T, et al. Social support in multiple sclerosis: associations with quality of life, depression, and anxiety. J Psychosom Res. 2020;138:110252–110252.
  • Oz HS, Oz F. A psychoeducation program for stress management and psychosocial problems in multiple sclerosis. Niger J Clin Pract. 2020;23(11):1598–1606.
  • Hanna M, Strober LB. Anxiety and depression in multiple sclerosis (MS): antecedents, consequences, and differential impact on well-being and quality of life. Mult Scler Relat Disord. 2020;44:102261.
  • De la Torre Gabriel G, Mato I, Doval S, et al. Neurocognitive and emotional status after one-year of mindfulness-based intervention in patients with relapsing-remitting multiple sclerosis. Appl Neuropsychol Adult. 2020;1–10.
  • Güner MC, Yazar MS, Meterelliyoz KŞ. Cognitive predictors of depression and anxiety in individuals with newly diagnosed multiple sclerosis. Eur J Psychiatry. 2020;34(4):202–210.
  • Taspinar O, Aydın T, Celebi A, et al. Psychological effects of calisthenic exercises on neuroinflammatory and rheumatic diseases. Z Rheumatol. 2015;74(8):722–727.
  • Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67(6):361–370.
  • Spielberger CD, Gorsuch RL, Lushene RE, et al. State-trait anxiety inventory. Palo Alto (CA): Mind Garden; 1983.
  • Hamilton MAX. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32(1):50–55.
  • Lovibond PF, Lovibond SH. The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the beck depression and anxiety inventories. Behav Res Ther. 1995;33(3):335–343.
  • Pilkonis PA, Choi SW, Reise SP, et al. Item banks for measuring emotional distress from the patient-reported outcomes measurement information system (PROMIS®): depression, anxiety, and anger. Assessment. 2011;18(3):263–283.
  • Beck AT, Epstein N, Brown G, et al. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988;56(6):893–897.
  • Derogatis LR, Spencer PM. Brief Symptom Inventory: BSI. Vol. 18. Upper Saddle River (NJ): Pearson; 1993.
  • Spitzer RL, Kroenke K, Williams JB, et al. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–1097.
  • Yardley L, Beyer N, Hauer K, et al. Development and initial validation of the Falls Efficacy Scale-International (FES-I). Age Ageing. 2005;34(6):614–619.
  • Khatibi A, Moradi N, Rahbari N, et al. Development and validation of fear of relapse scale for relapsing-remitting multiple sclerosis: understanding stressors in patients. Front Psychiatry. 2020;11:226.
  • Tahmassian K, Moghadam NJ. Relationship between self-efficacy and symptoms of anxiety, depression, worry and social avoidance in a normal sample of students. Iran J Psychiatry Behav Sci. 2011;5(2):91.
  • Mills N, Pajares F, Herron C. A reevaluation of the role of anxiety: self‐efficacy, anxiety, and their relation to reading and listening proficiency. Foreign Lang Ann. 2006;39(2):276–295.
  • Bandura A. Self-efficacy conception of anxiety. Anxiety Res. 1988;1(2):77–98.
  • Jayewardene WP, Lohrmann DK, Erbe RG, et al. Effects of preventive online mindfulness interventions on stress and mindfulness: a meta-analysis of randomized controlled trials. Prev Med Rep. 2017;5(C):150–159.
  • Bogosian A, Chadwick P, Windgassen S, et al. Distress improves after mindfulness training for progressive MS: a pilot randomised trial. Mult Scler. 2015;21(9):1184–1194.
  • Conn VS. Anxiety outcomes after physical activity interventions: meta-analysis findings. Nurs Res. 2010;59(3):224–231.
  • Latimer-Cheung AE, Pilutti LA, Hicks AL, et al. Effects of exercise training on fitness, mobility, fatigue, and health-related quality of life among adults with multiple sclerosis: a systematic review to inform guideline development. Arch Phys Med Rehabil. 2013;94(9):1800–1828.e3.
  • Learmonth YC, Motl RW. Physical activity and exercise training in multiple sclerosis: a review and content analysis of qualitative research identifying perceived determinants and consequences. Disabil Rehabil. 2016;38(13):1227–1242.
  • Dalgas U, Ingemann-Hansen T, Stenager E. Physical exercise and MS recommendations. Int MS J. 2009;16(1):5–11.
  • Halabchi F, Alizadeh Z, Sahraian MA, et al. Exercise prescription for patients with multiple sclerosis; potential benefits and practical recommendations. BMC Neurol. 2017;17(1):1–11.
  • Wang Y, Wang Y, Li R, et al. The epidemiology of alcohol consumption and multiple sclerosis: a review. Neurol Sci. 2015;36(2):189–196.
  • Paz-Ballesteros WC, Monterrubio-Flores EA, de Jesús Flores-Rivera J, et al. Cigarette smoking, alcohol consumption and overweight in multiple sclerosis: disability progression. Arch Med Res. 2017;48(1):113–120.
  • Haynes JC, Farrell M, Singleton N, et al. Alcohol consumption as a risk factor for anxiety and depression: results from the longitudinal follow-up of the National Psychiatric Morbidity Survey. Br J Psychiatry. 2005;187(6):544–551.
  • Vannucci A, Flannery KM, Ohannessian CM. Social media use and anxiety in emerging adults. J Affect Disord. 2017;207:163–166.
  • Baltacı Ö. The predictive relationships between the social media addiction and social anxiety, loneliness, and happiness. Int J Progress Educ. 2019;15(4):73–82.